wjc.v8.i5.333

NCAM-1/CD56 Antibody (C5.9) [PE] Summary

    Immunogen
    Made to Human CD56
    Specificity
    Recognises the human CD56 cell surface antigen, NKH-1, expressed by natural killer cells.
    Isotype
    IgG2b
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    NCAM1
    Purity
    IgG purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Flow Cytometry 1:10-1:1000
    Positive Control NCAM-1/CD56 Lysate (NBL1-13501)

Reactivity Notes

Cross reacts with Human.

Packaging, Storage & Formulations

    Storage
    Store at 4C. Do not freeze.
    Buffer
    PBS
    Preservative
    0.05% Sodium Azide
    Purity
    IgG purified

Alternate Names for NCAM-1/CD56 Antibody (C5.9) [PE]

      CD56 / NCAM-1
      CD56 antigen
      CD56
      MSK39
      NCAM1
      N-CAM-1
      NCAM-1
      NCAMantigen recognized by monoclonal 5.1H11
      neural cell adhesion molecule 1
      neural cell adhesion molecule, NCAM

Background

CD56, as a member of the immunoglobulin superfamily of adhesion molecules is characterized by several immunoglobulin (Ig) like domains. The extracellular part of CD56 consists of five of these Ig domains and two fibronectin type III homology regions. CD56 is encoded by a single copy gene composed of 26 exons. However, at least 20-30 distinct isoforms can be generated by alternative splicing and by posttranslational modifications, such as sialylation. During sialylation, polysialic acid (PSA) carbohydrates are attached to the extracellular part of CD56. Through its extracellular region, CD56 mediates homophilic interactions. In addition, CD56 can also undergo heterophilic interactions by binding extracellular matrix components, such as laminin, or other cell adhesion molecules, such as integrins. CD56 is expressed on most neuroectodermal derived cell lines, tissues and neoplasm such as retinoblastoma, medulloblastoma, astrocytomas and neuroblastoma.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bitopertin

Related Post